Vinblastine Injection Franchise in Ahmedabad

Anticancer Injection Supplier in Mumbai

Oncology Injection Distributor in Delhi

Hospital PCD Pharma Franchise in Bangalore

Vinblastine Injection Stockist in Hyderabad
Oncology Injection Manufacturer & Exporter in Chandigarh

Home/Products /vinblastine-1mg-injection

Vinbot 1 Injection

Composition : Vinblastine (1mg) Injection

Dosage Form : Injection

Packaging Type : Vial

Packaging : 10ml

Price : ₹1/-

Vinbot 1 Injection contains Vinblastine 1mg, a potent anticancer medication used for the treatment of various malignancies including Hodgkin’s lymphoma, non-Hodgkin’s lymphoma, leukemia, and testicular cancer. It is administered in controlled hospital and oncology settings.

Vinblastine works by inhibiting microtubule formation during mitosis, effectively stopping the division and proliferation of cancer cells. This mechanism plays a critical role in slowing tumor growth and disease progression.

This injection is commonly used as part of combination chemotherapy regimens, allowing oncologists to tailor dosing based on patient response and treatment protocols. Its injectable form ensures precise dosage and reliable bioavailability.

Vinbot 1 Injection contains Vinblastine 1mg, a vinca alkaloid anticancer agent used in chemotherapy. It works by inhibiting microtubule formation in rapidly dividing cells, thereby preventing cancer cell division and slowing tumor growth. The low-dose injectable formulation allows precise dosing and controlled administration in sensitive chemotherapy regimens under strict medical supervision.

Read More

About the Product

Vinbot 1 Injection contains Vinblastine 1mg, a potent anticancer medication used for the treatment of various malignancies including Hodgkin’s lymphoma, non-Hodgkin’s lymphoma, leukemia, and testicular cancer. It is administered in controlled hospital and oncology settings.

Vinblastine works by inhibiting microtubule formation during mitosis, effectively stopping the division and proliferation of cancer cells. This mechanism plays a critical role in slowing tumor growth and disease progression.

This injection is commonly used as part of combination chemotherapy regimens, allowing oncologists to tailor dosing based on patient response and treatment protocols. Its injectable form ensures precise dosage and reliable bioavailability.

Vinbot 1 Injection contains Vinblastine 1mg, a vinca alkaloid anticancer agent used in chemotherapy. It works by inhibiting microtubule formation in rapidly dividing cells, thereby preventing cancer cell division and slowing tumor growth. The low-dose injectable formulation allows precise dosing and controlled administration in sensitive chemotherapy regimens under strict medical supervision.

Common side effects may include nausea, vomiting, fatigue, hair loss, and mild bone marrow suppression. Serious side effects may include neutropenia, increased risk of infections, peripheral neuropathy, and allergic reactions. Regular monitoring of blood counts is advised during treatment.

Vinbot 1 Injection is indicated for the treatment of various malignancies including Hodgkin’s lymphoma, non-Hodgkin’s lymphoma, testicular cancer, breast cancer, and other cancers as determined by an oncologist. It is often used as part of combination chemotherapy protocols.

Vinbot 1 Injection must be administered only by trained healthcare professionals in a specialized clinical or hospital setting. Dosage should be carefully calculated based on patient condition. Patients should immediately report fever, unusual bleeding, or signs of infection to their doctor.

Store Vinbot 1 Injection in a cool, dry place, protected from light. Keep the vial tightly closed and out of reach of children. Do not use if the solution appears discolored or contains visible particles.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation